Similar articles

• Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.

  Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, Hameleers N, Wouters EFM, Janssen DJA. Verberkt CA, et al. JAMA Intern Med. 2020 Oct 1;180(10):1306-1314. doi: 10.1001/jamainternmed.2020.3134. JAMA Intern Med. 2020. PMID: 32804188 Free PMC article. Clinical Trial.
• The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.

  Allcroft P, Margitanovic V, Greene A, Agar MR, Clark K, Abernethy AP, Currow DC. Allcroft P, et al. J Palliat Med. 2013 Jul;16(7):741-4. doi: 10.1089/jpm.2012.0505. Epub 2013 Apr 18. J Palliat Med. 2013. PMID: 23597092 Clinical Trial.
• Low-Dose Morphine Does Not Cause Sleepiness in Chronic Obstructive Pulmonary Disease: A Secondary Analysis of a Randomized Clinical Trial.

  Altree TJ, Toson B, Loffler KA, Ekström M, Currow DC, Eckert DJ. Altree TJ, et al. Am J Respir Crit Care Med. 2024 Nov 1;210(9):1113-1122. doi: 10.1164/rccm.202310-1780OC. Am J Respir Crit Care Med. 2024. PMID: 38477675 Clinical Trial.
• Opioid Prescription Method for Breathlessness Due to Non-Cancer Chronic Respiratory Diseases: A Systematic Review.

  Yamaguchi Y, Saif-Ur-Rahman KM, Nomura M, Ohta H, Hirakawa Y, Yamanaka T, Hirahara S, Miura H. Yamaguchi Y, et al. Int J Environ Res Public Health. 2022 Apr 18;19(8):4907. doi: 10.3390/ijerph19084907. Int J Environ Res Public Health. 2022. PMID: 35457773 Free PMC article. Review.
• [Opioids for refractory dyspnoea in palliation].

  Aabom B, Bendstrup E, Sjøgren P, Løkke A, Shaker B, Wilcke T, Jespersen BA, Hilberg O, Marsaa K. Aabom B, et al. Ugeskr Laeger. 2020 Sep 28;182(40):V04200225. Ugeskr Laeger. 2020. PMID: 33000737 Review. Danish.